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Background: The aim of this study was to evaluate the impact of obesity on surgical outcome and
prognosis in patients with gastric cancer.
Methods: A total of 304 patients who underwent curative gastrectomy for gastric adenocarcinoma be-
tween January 2005 and March 2008were enrolled. Body mass index (BMI) was calculated before the
operation and visceral fat area (VFA) was measured by abdominal computed tomography (CT). The pa-
tients were divided according to BMI class and VFA quartile. The inﬂuence of BMI and VFA on surgical
outcome and survival was evaluated.
Results: The median BMI was 23.3 kg/m2 and the median VFA was 103 cm2. There was a signiﬁcant
positive correlation between BMI and VFA. According to BMI class and VFA quartile, there were no
signiﬁcant differences in patients’ characteristics or surgical outcome, with the exception of a signiﬁ-
cantly longer operation time and fewer retrieved lymph nodes in patients with a high BMI and VFA. The
unadjusted overall and disease free survival were not signiﬁcantly different between BMI classes or VFA
quartiles.
Conclusions: Obesity, as represented by BMI and VFA, may not be a poor prognostic factor in patients
with gastric cancer.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
According to 2013 World Health Organization report, over-
weight and obesity are the ﬁfth leading risk for global deaths and
at least 2.8 million adults die each year as a result of being
overweight or obese [1]. Obesity has been correlated with an
increased risk of various serious disease processes, including
malignancy. Many epidemiological studies have indicated that
obesity is associated with an increased incidence of cancer of the
colon, breast, endometrium, kidney, and esophagus [2,3]. Similar
to other malignancy, overweight and a high body mass index
(BMI) are associated with an increased risk of gastric adenocar-
cinoma [4].
BMI is a simple index of weight-for-height that is commonly
used to assess obesity. However, BMI is an imperfect measurementVincent’s Hospital, College of
Ji-dong, Paldal-gu, Suwon,
1 249 7170; fax: þ82 31 247
003@catholic.ac.kr (K.H. Jun).
ciates Ltd. Published by Elsevier Ltof abnormal or excessive fat accumulation, both because this value
does not distinguish fat mass from lean bodymass components and
because the distribution of fat tissue differs greatly between in-
dividuals. Accordingly, visceral fat area (VFA) has been proposed as
an alternative to BMI for assessment of the impact of obesity and fat
distribution [5,6].
Several previous studies have suggested that obesity nega-
tively affects the outcome of surgical treatment and results in a
longer operative time, more blood loss during operations, and an
increased risk of postoperative morbidity in patients with gastric
cancer [6,7]. A higher BMI is not an independent prognostic
factor for long-term survival in gastric cancer but is associated
with more postoperative complications [8,9]. In recent studies,
VFA was more accurate than BMI as a predictor of perioperative
complications, operation time and blood loss [6,10e12].
Although the inﬂuence of BMI on the prognosis of patients with
gastric cancer has been investigated, the relationship between
VFA and prognosis of patient with gastric cancer remains
controversial.
The aim of this study was to assess the inﬂuence of obesity and
body fat distribution on surgical outcomes and overall survival after
gastrectomy for gastric adenocarcinoma.d. All rights reserved.
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2.1. Patients
A total of 304 patients who underwent subtotal gastrectomy or
total gastrectomy for primary gastric cancer between January 2005
and March 2008, at the Department of Surgery, St. Vincent’s Hos-
pital, The Catholic University of Korea, were enrolled in the study.
The Institutional Review Board of St. Vincent’s Hospital approved
this study (VC13RISI0075). All included patients underwent
abdominal computed tomography (CT) as a preoperative evalua-
tion. We excluded patients (1) who had distant metastasis, (2) who
underwent palliative operation or R1 resection, and (3) for whom
VFA could not be calculated from the abdominal CT in the work-
station. This study included patients who underwent curative
gastrectomy with R0 resection (230 subtotal gastrectomy and 74
total gastrectomy cases) and lymph node dissectionwas performed
based on the Gastric cancer treatment guidelines in Japan [13]. D2
lymph node dissection was performed in patients with advanced
gastric cancer, whereas D1 plus lymph node dissection was per-
formed in patients with early gastric cancer. The stage and histo-
pathological classiﬁcation of disease was based on the Japanese
Classiﬁcation of Gastric Carcinoma [14].
2.2. Data collection
Demographic, operative, perioperative, radiologic and patho-
logic data from all patients were obtained from a retrospective
medical record review. Prior to surgery, BMI was calculated as
weight divided by height squared (kg/m2). Operative time, intra-
operative blood loss, intraoperative transfusion, the number of
lymph nodes retrieved, postoperative complications, and the
duration of the postoperative hospital stay were investigated as
surgical outcomes. Follow-up was based on outpatient evaluation
according to a predetermined schedule. The protocol included
clinical and hematological examinations, chest X-rays, upper
gastrointestinal endoscopic assessment, and CT. Follow-up wasFig. 1. Quantiﬁcation of visceral fat area. The outer red line was manually generated with a cu
red line indicates visceral fat (b, d). These pictures are from individuals who had differentclosed on April 30, 2013. All surviving patients were followed up for
at least 5 years, and the mean follow-up period in these cases was
64 months.2.3. Measurement of total fat area and visceral fat area
The total fat area (TFA) and VFA were measured using a cross-
sectional image from 16-detector row CT imaging of the abdomen
(Somatom Sensation 16, Siemens Medical Solutions, Forchheim,
Germany) at the level of the umbilicus (Fig. 1). On CT scans, adipose
tissue was determined by setting the attenuation level within the
range of 190 to 30 Hounsﬁeld units (HU). To measure these
parameters, the fat margin was manually traced and the cross-
sectional area of each parameter was calculated in cm2 using CT
Software (Rapidia 2.8; INFINITT, Seoul, Korea). The subcutaneous
fat area (SFA) was obtained by determining the difference between
the TFA and the VFA.2.4. Statistical methods
Values were expressed as a percentage or median (quartile), as
appropriate. Correlations were studied using Pearson’s r correla-
tion. Fisher’s exact test was used to compare differences in discrete
or categorical variables and the KruskaleWallis test was used for
continuous variables. BMI was categorized as underweight
(<18.5 kg/m2), normal weight (18.5e22.9 kg/m2), overweight
(23.0e24.9 kg/m2), obese grade I (25.0e29.9 kg/m2), or obese grade
II (30.0 kg/m2) as described by the World Health Organization/
International Association for the Study of Obesity/International
Obesity Task Force (2000): Asian-Paciﬁc standard [15]. Surface
areas were categorized using the quartiles as the cutoff point.
Overall survival was estimated by KaplaneMeier method, the log-
rank test was used to compare survival curves, and Cox propor-
tional hazards models were used to obtain the hazard ratio.
P < 0.05 was considered to indicate a statistically signiﬁcant dif-
ference with a 95% conﬁdence interval (95% CI).rsor to determine the total fat area (a, c), in which attenuationwas measured. The inner
distribution of fat tissue despite having the same BMI.
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3.1. Patients’ characteristics
The characteristics of the subjects are shown in Table 1. Of a total
of 304 patients, 207 (68.1%) were male, and the median age was 60
years old (range, 25e86). In total, 14% of patients had a diagnosis of
diabetes mellitus that required oral hypoglycemic agents and/or
insulin injection before operation. Moreover, 27% of patients had
hypertension at the time of the initial preoperative surgical eval-
uation. The mean BMI of the patients in this study was 23.3 kg/m2
(range, 15.6e34.9). The ﬁnal pathologic stage prognostic groups
according to the seventh American Joint Commission for Cancer
(AJCC, 7th edition) were 153 patients (50.3%) with stage I disease,
77 patients (25.3%) with stage II disease, and 74 patients (24.3%)
with stage III disease. All patients had undergone a curative gas-
trectomy with standard lymph node dissection. More than 75% of
the patients were treated with subtotal gastrectomy and the
remaining patients were treated with total gastrectomy. The me-
dian operative time was 227.5 min (range, 110e610) and the me-
dian blood loss was 200ml (range, 50e1500). The median numbers
of retrieved lymph nodes was 30 (range, 16e74). D2 lymph node
dissection was performed in 57.9% of patients, whereas D1 plusTable 1
Clinicopathological characteristics of 304 patients.
Basic characteristics Values (%)
Age (year) 60 (25e86)
Gender
Male 207 (68.1)
Female 97 (31.9)
Tumor size (cm) 3.2 (0.4e18.0)
Hypertension
Negative 220 (72.4)
Positive 84 (27.6)
Diabetes
Negative 290 (95.4)
Positive 14 (4.6)
BMI (kg/m2) 23.3 (15.6e34.9)
Total fat area (cm2) 228.5 (12e603)
Subcutaneous fat area (cm2) 112 (1e343)
Visceral fat area (cm2) 103 (11e400)
T stage
T1 138 (45.4)
T2 42 (13.8)
T3 74 (24.3)
T4 50 (16.4)
N stage
N0 181(59.5)
N1 43 (14.1)
N2 37 (12.2)
N3 43 (14.1)
TNM stage
I 153 (50.3)
II 77 (25.3)
III 74 (24.3)
Operation time (min) 227.5 (110e610)
Blood loss (ml) 200 (50e1500)
Transfusion
Negative 277 (91.1)
Positive 27 (8.9)
No. of lymph nodes 30 (14e74)
Surgical procedure
Subtotal gastrectomy 230 (75.7)
Total gastrectomy 74 (24.3)
Lymph node dissection
D1 þ alpha, beta 128 (42.1)
D2 176 (57.9)
Postoperative complication
Negative 276 (90.8)
Positive 28 (9.2)alpha or beta was performed in 42.1% of patients. Postoperative
complications were reported in 28 (9.2%) patients. In descending
order, the three most frequent complications were postoperative
ileus (39.3%), delayed gastric emptying (21.4%), and anastomotic
site stenosis (17.9%).3.2. Distribution of BMI and VFA
Within the group of 304 patients, 7.2% (n ¼ 22) were under-
weight (under 18.5 kg/m2), 39.1% (n ¼ 119) had a normal weight
(18.5e22.9 kg/m2), 26% (n¼ 79) were overweight (23e24.9 kg/m2),
25.6% (n¼ 78) were obesity grade I (25e29.9 kg/m2), and 2% (n¼ 6)
were obesity grade II (over 30 kg/m2). The median BMI was 23.3 kg/
m2 (range, 15.5e34.9). The median VFA was 103 cm2 (range, 11e
400). There was a signiﬁcant positive correlation between BMI and
VFA (P < 0.001; r ¼ 0.7), although a wide range of VFA existed
within each BMI class as shown in Fig. 2.3.3. Subgroup analysis according to BMI class and VFA quartile
Clinicopathological characteristics according to BMI and VFA
distribution are summarized in Tables 2 and 3. There was aFig. 2. Visceral fat area distribution according to body mass index as a continuous
variable (a) or as a categorical variable (b).
Table 2
Population characteristics of 304 patients according to BMI and VFA distribution.
Characteristics BMI, kg/m2 P
<18.5 (underweight) 18.5e22.9 (normal) 23e24.9 (overweight) 25e29.9 (obesity grade I) 30 (obesity grade II)
No. of patients 22 119 79 78 6
Sex
Male 17 (77.3) 79 (66.4) 55 (69.6) 53 (67.9) 3 (50) 0.735
Female 5 (22.8) 40 (33.6) 24 (30.4) 25 (32.1) 3 (50)
Age (year) 58 (38e81) 59 (26e86) 60 (32e81) 60.5 (25e82) 64 (60e70) 0.852
Hypertension
Negative 16 (72.7) 92 (77.3) 55 (69.6) 54 (69.2) 3 (50) 0.457
Positive 6 (27.3) 27 (22.7) 24 (30.4) 24 (30.8) 3 (50)
Diabetes
Negative 22 (100) 115 (96.6) 74 (93.7) 73 (93.6) 6 (100) <0.001
Positive 0 (0) 4 (3.4) 5 (6.3) 5 (6.4) 0 (0)
Total fat area (cm2) 83.7 (12.2e166) 170.5 (26.5e503.7) 247.7 (122.9e374.4) 315.7 (145.1e602.6) 473.3 (349.7e534.3) <0.001
Subcutaneous fat area (cm2) 49 (1e96) 92 (6e310) 124 (51e227) 156 (79e343) 229.5 (157e312) <0.001
Visceral fat area (cm2) 36.4 (11.1e109.3) 76 (19.5e194) 111.4 (32.1e221.8) 157.5 (16.8e400) 225.8 (179.7e297.9) <0.001
Operation time (min) 210 (110e610) 220 (130e415) 230 (120e390) 240 (150e355) 240 (150e420) 0.015
Blood loss (ml) 400 (50e1000) 200 (50e1500) 150 (50e700) 250 (50e800) 175 (200e600) 0.607
Transfusion
Negative 19 (86.4) 110 (92.4) 74 (93.7) 69 (88.5) 5 (83.4) <0.001
Positive 3 (13.6) 9 (7.6) 5 (6.4) 9 (11.5) 1 (16.7)
Postoperative complication
Negative 14 (63.6) 108 (90.8) 73 (92.4) 70 (89.7) 6 (100) <0.001
Positive 8 (36.4) 11 (9.2) 6 (7.6) 8 (10.3) 0 (0)
No. of lymph nodes 29.5 (14e56) 32 (16e74) 31 (16e61) 28 (16e59) 18.5 (16e28) 0.001
TNM stage
I 6 (27.3) 65 (54.6) 39 (49.4) 38 (48.7) 5 (83.3) 0.004
II 6 (27.3) 19 (16) 24 (30.4) 28 (35.9) 0 (0)
III 10 (45.5) 35 (29.4) 16 (20.3) 12 (15.4) 1 (16.7)
Hospital day 12 (9e53) 10 (7e44) 11 (7e27) 10.5 (8e34) 11 (9e18) 0.040
Lymph node dissection
D1 þ alpha, beta 4 (18.2) 41 (34.5) 30 (38) 48 (61.5) 5 (83.3) <0.001
D2 18 (81.8) 78 (65.5) 49 (62) 30 (38.5) 1 (16.7)
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(P<0.001). Therewaspositive associationbetweenVFAquartile and
hypertension (P < 0.001), and VFA was signiﬁcantly increased in
older patients (P < 0.001). The median TFA, SFA, and VFA increased
within each BMI class (P < 0.001) and VFA quartile (P < 0.001). A
higher BMI/VFA was correlated with a longer operation time,
without a signiﬁcant correlation with blood loss or transfusion.
There was no signiﬁcant difference in postoperative complications
between BMI classes or VFA quartiles. There was a signiﬁcant dif-
ference according to BMI class and VFA quartile regarding the
number of retrieved lymph nodes and lymph node dissection. In
higher BMI/VFA group, the number of retrieved lymph nodes was
decreased and D1 plus alpha or beta dissection was frequently per-
formed rather thanD2dissection.However, no signiﬁcant difference
in the pathologic TNM stage or hospital day was observed.
3.4. Overall survival according to BMI class and VFA quartile
The median survival was 59.5 months (range, 8e97), with a
median follow-up period of 62 months (range, 26e97) for patients
who were alive the last follow-up. The 5-year overall survival was
81%. Overall survivalwas not signiﬁcantly different according toBMI
classes or VFA quartiles and no multivariate model was tested
because no statistical signiﬁcance was found in an univariate anal-
ysis (Table 4, Fig. 3). Disease free survival was not different between
BMI classes or VFA quartiles. Furthermore, the pattern of recurrence
wasnot signiﬁcantly different according toBMI class or VFAquartile.
4. Discussion
Many large-scale studies have reported on the relationship be-
tween obesity and malignancy, given the increasing worldwideprevalence of overweight and obese individuals. It is well known
that obesity is an important contributor to cancer risk and that
excessive adipose tissue can exert systemic effects that are puta-
tively involved in cancer biology such as metabolic syndrome [16].
Adipose tissue secretes various adipokines, such as tumor ne-
crosis factor (TNF), IL-6, leptin, and insulin-like growth factor (IGF-
1), which are considered to have pathologic effects in gastrointes-
tinal cancer, in addition to the mechanical effects of obesity
including higher intra-abdominal pressure and resulting gastro-
esophageal reﬂux. Furthermore, central fat, also referred to as
visceral fat, has moremetabolic activity than dose subcutaneous fat
[16,17]. In the MEtabolic SyndRome and abdominaL ObesiTy
(MERLOT) study, the authors demonstrated that intra-abdominal
fat area measured by CT is the most accurate parameter for
assessing abdominal obesity and that range of VFA varied widely
among subjects with the same BMI [18]. Our results showed a
positive correlation between BMI and VFA, although awide range of
VFA was present within each BMI class. Yoshikawa et al. reported
that 33.3% of BMI-low (<25 kg/m2) patients were VFA-high
(>100 cm2), and referred to these patients as “viscerally obese”
patient [5]. These results supported the usefulness of VFA as a good
parameter to assess abdominal obesity even in patients with a
normal BMI.
Many previous studies have shown that obese patients with a
high BMI have unfavorable surgical outcomes, including a longer
operative time, more postoperative complications, an increased
conversion rate, and a prolonged hospital stay [19,20]. Kang et al.
reported that anastomosis leakage may occur in cases in which
there is excessive tension and pressure on the anastomosis site and
that these conditions are more frequently observed in patients with
excessive visceral fat because the thick mesentery creates tension
on the anastomosis [21]. Certain authors emphasized that VFA is
Table 3
Population characteristics of 304 patients according to VFA for 403 patients.
Characteristics VFA, quartile, cm2 P
First (<69) Second (69e103) Third (103e150) Fourth (>150)
No. of patients 75 78 78 73
Sex
Male 54 (72) 46 (59) 50 (64.1) 57 (78.1) 0.059
Female 21 (28) 32 (41) 28 (35.9) 16 (21.9)
Age (year) 54 (31e78) 56 (25e86) 60 (33e81) 66 (38e82) <0.001
Hypertension
Negative 69 (92) 61 (78.2) 48 (61.5) 42 (57.5) <0.001
Positive 6 (8) 17(21.8) 30 (38.5) 31 (42.5)
Diabetes
Negative 72 (96) 75 (96.2) 76 (97.4) 67 (91.8) 0.380
Positive 3 (4) 3 (3.8) 2 (2.6) 6 (8.2)
Total fat area (cm2) 114 (12e280) 195 (109.8e358.2) 250.6 (157.9e481.7) 339.1 (249.7e602.6) <0.001
Subcutaneous fat area (cm2) 61.9 (1.2e247.9) 105.3 (31.8e272.4) 126.2 (48.6e342.7) 148 (79.1e312.1) 0.009
BMI (kg/m2) 20.4 (16.7e27.1) 22.3 (15.6e27.9) 24.2 (16.8e28.8) 26 (19.7e34.9) <0.001
Operation time (min) 210 (135e330) 220 (110e610) 230 (120e390) 240 (150e420) 0.021
Blood loss (ml) 150 (50e1000) 175 (50e800) 200 (50e1500) 400 (50e700) 0.571
Transfusion
Negative 67 (89.3) 72 (92.3) 73 (93.6) 65 (89.1) 0.892
Positive 8 (10.6) 6 (7.7) 5 (6.4) 8 (10.9)
Postoperative complication
Negative 68 (90.7) 72 (92.3) 71 (91) 65 (89) 0.773
Positive 7 (9.3) 6 (7.7) 7 (9) 8 (11)
No. of lymph nodes 31 (14e58) 32 (16e67) 33(16e61) 27 (16e74) <0.001
TNM stage
I 38 (50.7) 41 (52.6) 34 (43.6) 40 (53.8) 0.352
II 14 (18.7) 19 (24.4) 26 (33.3) 18 (23.7)
III 24 (30.7) 18 (23.1) 18 (23.1) 15 (20.5)
Hospital day 10 (7e53) 10 (7e44) 11 (7e40) 10 (7e31) 0.144
Lymph node dissection
D1 þ alpha, beta 26 (34.7) 27 (34.6) 33 (42.3) 42 (57.5) 0.014
D2 49 (65.3) 51 (65.4) 45 (57.7) 31 (41.5)
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BMI [6,10,11]. In the present study, we examined 28 cases (9.2%) of
postoperative complications, but we could ﬁnd no differences in
the incidence of postoperative complications, blood loss, or hospital
stay between each BMI classes or VFA quartiles.
Our results showed there are signiﬁcant differences in the
operation time and the number of retrieved LNs according to BMI
classes and VFA quartiles. A longer operation time for obese pa-
tients is predictable and has been reported repeatedly [21,22].
Several studies have reported that a high BMI or VFA is signiﬁcantly
correlated with a decreased number of retrieved LNs, indicating
that excessive intra-abdominal fat precludes the complete dissec-
tion of LNs [5,20]. The LNs and major vessels are covered with
abundant adipose tissue in obese patients, further resulting in a
poor view of the surgical ﬁeld and more difﬁculty in achieving
precision in the complete procedure. Clinically, retrieving moreTable 4
Inﬂuence of BMI and VFA on overall survival.
Characteristics No. 5 year
survival rate
HR (95% CI) P value
BMI
Underweight (<18.5) 22 66.1 2.225 (0.23e21.49) 0.490
Normal (18.5e22.9) 119 80 1.179 (0.14e9.97) 0.880
Overweight (23e24.9) 79 82 0.984 (0.12e8.17) 0.988
Obesity grade I (25e29.9) 78 85.4 0.902 (0.12e7.09) 0.922
Obesity grade II (30) 6 83.3 1 e
VFA quartile
First (<69) 75 87.9 0.947 (0.36e2.48) 0.911
Second (69e103) 78 81.6 0.929 (0.38e2.30) 0.873
Third (103e150) 78 76.1 1.513 (0.69e3.31) 0.299
Fourth (>150) 73 85.7 1 ethan 15 LNs is essential for the accurate N staging and is considered
more important than actual number of retrieved LNs [23]. In our
study, the number of retrieved LNs in the group with BMI > 30 kg/
m2 was more than 16 and the percentages indicating fewer LNs
retrieved were not signiﬁcantly different between each BMI classes
or VFA quartiles.
Many investigators expect that a high BMI and a high VFA are
associated with a poor prognosis in patients with gastric cancer
because many previous studies have shown a strong correlation
between BMI and postoperative morbidity and a decreased number
of harvested lymph nodes. Insufﬁcient lymph node dissection could
result in inadequate staging, which is associated with poor prog-
nosis, likely due to stage migration. However, Tokunaga et al. re-
ported the largest study analyzing the correlation between BMI and
long-term survival in Japan and unexpectedly found that the 5-year
survival rate in the high BMI group was signiﬁcantly higher than in
the normal BMI group [8]. Additionally, the authors suggested the
different proportion of obese patients between Western and
Eastern populations as a limitation. In contrast, Kulig et al. reported
that overweight is not a poor prognostic factor in patients with
gastric cancer in a Western population [9]. The researchers also
described the median survival of overweight patients with
BMI  25 kg/m2 was signiﬁcantly higher than the median survival
of those patients with BMI < 25 kg/m2. Whereas previous reports
have commonly used BMI as a tool for assessing obesity, there are
few studies that have investigated the impact of VFA on long-term
survival in patients with gastric cancer. In our study, we analyzed 5-
year survival and recurrence according to VFA quartile and there
was no signiﬁcant correlation between VFA and overall survival, as
for BMI.
Our study has certain limitations. First, because our study was
designed as a retrospective case-control study and given that this
Fig. 3. Overall survival rate according to BMI (a) and VFA quartile (b). Blue, under-
weight (n ¼ 22) or ﬁrst VFA quartile; green, normal (n ¼ 119) or second VFA quartile;
red, overweight (n ¼ 79) or third VFA quartile; purple, obesity grade I (n ¼ 78) or fourth
VFA quartile; black, obesity grade II (n ¼ 6).
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selection bias. Second, our study did not record speciﬁc post-
operative complications according to standardized deﬁnitions.
Thus, we might not be able to conﬁrm a concrete interaction be-
tween VFA and postoperative complications. Further in-
vestigations are needed to determine the relationship between
those factors.
In conclusion, our study did not ﬁnd BMI or VFA to be correlated
with surgical outcome or overall survival in patients with resected
gastric adenocarcinoma. Additionally, VFA was not a more accurate
measurement of the systemic consequences of obesity than was
BMI. Clinicians should not change their surgical plan according to
BMI or VFA, but should be aware of the longer operation time and
more technical difﬁculties in LN dissection.
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